Showing results (1841-1850 of 6,517) with videos related to
Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|March 17, 2004
Antitumor effects of fusions composed of dendritic cells and fibroblasts transfected with genomic DNA from tumor cellsMotoyuki Nakamura, Tetsuro Kikuchi, Donald W Kufe, et al.Cancer Immunology, Immunotherapy : CII|January 14, 2005
Semi-mature IL-12 secreting dendritic cells present exogenous antigen to trigger cytolytic immune responsesThomas Felzmann, Katharina Gabriele Hüttner, Sabine Konstanze Breuer, et al.Cancer Immunology, Immunotherapy : CII|January 1, 2005
Binding parameters of antibodies: pseudo-affinity and other misconceptionsM Jules MattesCancer Immunology, Immunotherapy : CII|January 1, 2005
Treatment of stage III-IV nasopharyngeal carcinomas by external beam irradiation and local low doses of IL-2John J L Jacobs, Gerrit J Hordijk, Ina M Jürgenliemk-Schulz, et al.Cancer Immunology, Immunotherapy : CII|January 1, 2005
Dendritic cells generated from acute myeloid leukemia (AML) blasts maintain the expression of immunogenic leukemia associated antigensLi Li, Peter Reinhardt, Anita Schmitt, et al.Cancer Immunology, Immunotherapy : CII|January 1, 2005
A phase I vaccination study with tyrosinase in patients with stage II melanoma using recombinant modified vaccinia virus Ankara (MVA-hTyr)Ralf G Meyer, Cedrik M Britten, Ulrike Siepmann, et al.Cancer Immunology, Immunotherapy : CII|February 8, 2005
Tumor-specific immunity in MUC1.Tg mice induced by immunization with peptide vaccines from the cytoplasmic tail of CD227 (MUC1)Karl G Kohlgraf, Andrew J Gawron, Michiyo Higashi, et al.Cancer Immunology, Immunotherapy : CII|February 8, 2005
Comparison of PSA-specific CD8+ CTL responses and antitumor immunity generated by plasmid DNA vaccines encoding PSA-HSP chimeric proteinsMaxim Pavlenko, Anna-Karin Roos, Christoph Leder, et al.Cancer Immunology, Immunotherapy : CII|February 8, 2005
Modulation of monocyte-tumour cell interactions by Mycobacterium vaccaeJarosaw Baran, Monika Baj-Krzyworzeka, Kazimierz Weglarczyk, et al.Cancer Immunology, Immunotherapy : CII|February 3, 2005
Local interleukin 2 therapy is most effective against cancer when injected intratumourallyJohn J L Jacobs, Derek Sparendam, Willem Den OtterPageof 652